Additional chromosomal abnormalities in Philadelphia

Additional chromosomal abnormalities in Philadelphiapositive clone: adverse prognostic influence on frontline
imatinib therapy: a GIMEMA Working Party on CML
analysis
by Simona Luatti, Fausto Castagnetti, Giulia Marzocchi, Carmen Baldazzi, Gabriele
Gugliotta, Ilaria Iacobucci, Giorgina Specchia, Lucia Zanatta, Giovanna RegeCambrin, Marco Mancini, Elisabetta Abruzzese, Alfonso Zaccaria, Maria Grazia
Grimoldi, Alessandro Gozzetti, Gaia Ameli, Maria Adele Capucci, Giandomenico
Palka, Paolo Bernasconi, Francesca Palandri, Fabrizio Pane, Giuseppe Saglio,
Giovanni Martinelli, Gianantonio Rosti, Michele Baccarani, and Nicoletta Testoni
Blood
Volume 120(4):761-767
July 26, 2012
©2012 by American Society of Hematology
Cytogenetic and molecular response.
Simona Luatti et al. Blood 2012;120:761-767
©2012 by American Society of Hematology
Long-term outcome.
Simona Luatti et al. Blood 2012;120:761-767
©2012 by American Society of Hematology